This calculator is intended for use by health care providers. The results should not be used alone to determine medical treatment.

The Mayo PSC risk score utilizes the patients age, bilirubin, albumin, AST and a prior history of variceal bleeding, was developed to predict short term ...

10 янв. 2019 г. · The Mayo risk score is commonly used by clinicians to advise patients with primary sclerosing cholangitis (PSC) regarding their prognosis.

The Revised Natural History Model for Primary Sclerosing Cholangitis estimates survival probability of a patient with primary sclerosing cholangitis.

The Mayo risk score has been used more frequently to estimate short term survival for the end stage liver disease of patients with PSC, unfortunately, it was ...

The revised Mayo Risk Score was published in 2000 and aimed to eliminate histologic staging and more subjective variables (e.g., inflammatory bowel disease, ...

The Mayo Risk Score was one of the first non-invasive short-term (4 years) predictors of patient survival in PSC. UK-PSC Risk Score (published December 2018). ' ...

The c-statistics for transplant-free survival for the Mayo risk model and the long-term UK-PSC model are 0.68 and 0.85, respectively. The c-statistics for ...

The Mayo risk score (MRS) is the most frequently used score to assess the short-term (4-year) mortality risk of patients with PSC. However, this score was ...

This calculator is intended for use by health care providers. The results should not be used alone to determine medical treatment.